RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.94B
AUM Growth
+$3.94B
(+8.1%)
Cap. Flow
+$90.3M
Cap. Flow
% of AUM
2.29%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
163
New
20
Increased
50
Reduced
30
Closed
15
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$50.5M |
| 2 |
INZY
Inozyme Pharma
INZY
|
$23.1M |
| 3 |
Kymera Therapeutics
KYMR
|
$22.9M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$21.4M |
| 5 |
Humana
HUM
|
$21.3M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$41.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$31.6M |
| 3 |
Cigna
CI
|
$30.2M |
| 4 |
Amgen
AMGN
|
$29.7M |
| 5 |
Allogene Therapeutics
ALLO
|
$18.9M |
Sector Composition
| 1 | Healthcare | 90.05% |
| 2 | Consumer Staples | 1.43% |
| 3 | Consumer Discretionary | 0.93% |
| 4 | Industrials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iRhythm Technologies
IRTC
$5.46B
| $149M | 3.78% | 625,000 -26,000 | -4% | -$6.19M |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $141M | 3.58% | 1,465,500 +99,000 | +7% | +$9.52M |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $135M | 3.43% | 1,587,500 -90,179 | -5% | -$7.67M |
|
4
UnitedHealth
UNH
$281B
| $126M | 3.2% | 405,000 | – | – |
|
|
5
Humana
HUM
$36.5B
| $100M | 2.55% | 242,500 +51,500 | +27% | +$21.3M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $88.3M | 2.24% | 952,773 -7,256 | -0.8% | -$673K |
|
7
Intuitive Surgical
ISRG
$170B
| $85.1M | 2.16% | 120,000 | – | – |
|
8
Centene
CNC
$14.3B
| $77M | 1.95% | 1,320,000 +5,000 | +0.4% | +$292K |
|
9
argenx
ARGX
$43.6B
| $75.5M | 1.92% | 287,500 | – | – |
|
10
Insulet
PODD
$23.9B
| $74.6M | 1.89% | 315,500 +22,500 | +8% | +$5.32M |
|
11
Zai Lab
ZLAB
$3.68B
| $68.5M | 1.74% | 823,527 +10,281 | +1% | +$855K |
|
|
NVTA
12
DELISTED
Invitae Corporation
NVTA
| $65.8M | 1.67% | 1,517,962 +6,835 | +0.5% | +$296K |
|
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $64.9M | 1.65% | 1,573,200 +518,200 | +49% | +$21.4M |
|
14
Novavax
NVAX
$1.21B
| $63.5M | 1.61% | 585,705 +15,107 | +3% | +$1.64M |
|
15
HCA Healthcare
HCA
$94.5B
| $62.3M | 1.58% | 500,000 -49,500 | -9% | -$6.17M |
|
|
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $61.6M | 1.56% | 215,000 | – | – |
|
17
Pacira BioSciences
PCRX
$1.2B
| $60.4M | 1.53% | 1,005,000 +80,000 | +9% | +$4.81M |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $57.9M | 1.47% | 348,761 | – | – |
|
19
Freshpet
FRPT
$2.72B
| $56.6M | 1.43% | 506,500 +30,500 | +6% | +$3.41M |
|
20
Agios Pharmaceuticals
AGIO
$2.19B
| $55.4M | 1.4% | 1,581,509 +401,789 | +34% | +$14.1M |
|
|
NVRO
21
DELISTED
NEVRO CORP.
NVRO
| $53.8M | 1.36% | 386,000 | – | – |
|
22
Baxter International
BAX
$12.7B
| $51.9M | 1.32% | 645,000 | – | – |
|
|
HZNP
23
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $50.5M | 1.28% | +650,000 | New | +$50.5M |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $49.5M | 1.26% | 339,814 -5,186 | -2% | -$755K |
|
25
Idexx Laboratories
IDXX
$51.8B
| $49.1M | 1.25% | 125,000 | – | – |
|